China Resources Double-Crane Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on China Resources Double-Crane Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date China Resources Double-Crane Pharmaceutical Co Ltd Strategy Report
- Understand China Resources Double-Crane Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on China Resources Double-Crane Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
02 Aug 2022 | China Resources Shuanghe Acquires 50.11% Equity of Shenzhou Biotechnology | Acquisition |
China Resources Double-Crane Pharmaceutical Co Ltd
|
Shenzhou Biotechnology Co., Ltd.
|
21 Oct 2021 | China Resources Double-Crane Pharma (CRDC) Enters into Licensing Agreement with Ligand Pharma | Licensing Agreement |
China Resources Double-Crane Pharmaceutical Co Ltd
|
Ligand Pharmaceuticals Inc |
28 Jul 2021 | China Resources Double Crane Pharma Enters into Licensing Agreement with Novita Pharma | Licensing Agreement |
China Resources Double-Crane Pharmaceutical Co Ltd
|
Novita Pharmaceuticals Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer